Pain Relief
Not all cancers hurt. But some do. And for some, the cure feels worse than the disease. Whether it’s recovering from surgery or side effects of treatment, pain management can become an additional concern.
Here are some resources to get you started in the right direction:
- Alliance of State Pain Initiatives
- 608-265-4013
- http://aspi.wisc.edu
Provides leadership and advocacy for state and regional pain initiatives.
- American Pain Foundation
- 888-615-7246
- www.painfoundation.org
Features a Pain Action Guide and offers informational material, support and advocacy.
- Partners Against Pain
- www.partnersagainstpain.com
Includes news updates, pain control guides for patients, support groups, resources and additional information for healthcare professionals.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
